stockmarketproxy
/
PENNYSE SEC EDGAR

Penumbra Inc

Surgical & Medical Instruments & Apparatus·ALAMEDA, CA·FY end 12/31·CIK 1321732
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$1.4B$1.2B$284.7M$221.2M$204.0M
Gross Profit$942.4M$755.0M$187.0M$138.4M$125.4M
Operating Income$189.2M$9.3M$73.6M$6.1M-$7.5M
Net Income$177.7M$14.0M$54.2M$3.9M-$24.6M
Operating CF$238.7M$168.5M$97.3M-$55.7M$9.5M
Capex$63.7M$21.2M$15.2M$19.3M$21.2M
Free Cash Flow$174.9M$147.3M$82.1M-$75.0M-$11.7M
Buybacks$0$100.4M———
Dividends——————
Gross Margin67.1%63.2%65.7%62.6%61.5%
Operating Margin13.5%0.8%25.8%2.7%-3.7%
Net Margin12.7%1.2%19.0%1.8%-12.1%
FCF Margin12.5%12.3%28.8%-33.9%-5.7%
R&D / Revenue——————
Effective Tax13.4%32.9%-42.1%45.6%39.9%
Debt / Equity——————
Buybacks / FCF0.0%68.2%———

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
PEN
11:1
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BAX
257:1
CEO total comp
PEN
$1M
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BAX
$18M
Net Margin
PEN
12.7%
BSX
—
SYK
11.8%
MMM
13.0%
PODD
9.1%
BAX
-8.5%